Urologix   Report issue

For profit Phase 3
Founded: Minneapolis MN United States (1991)
Status: Left NME R&D (2004)

Organization Overview

First Clinical Trial
2004
NCT00064649
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2004

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (2)

alfuzosin (uroxatral) (1 trial)

finasteride (Proscar) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hyperplasia (Phase 3)

Prostatic Hyperplasia (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2